BioSpace News Archive

-- Proceeds Will Advance Growing Portfolio of Novel Immunomedicine Drug Candidates --

Earnings and business update call scheduled for 9:00 am ET today

Mesa Biotech Inc., a privately-held, molecular diagnostic company that has developed an affordable and easy to operate PCR (polymerase chain reaction) testing platform designed specifically for point-of-care (POC), today announced it has obtained CE Mark in the European Union (EU) for its Accula™ RSV Test.

Provides Non-Dilutive Resources to Fund the Company’s Growth Initiatives

BIONIK Laboratories Corp. today announced financial results for the second quarter of fiscal year 2019, ended September 30, 2018.

CANbridge Pharmaceutical Inc. announced that it appointed Jeff Lau as Vice President of Finance and Controller, effective September 10th, and Fangzhou Cheng, as Vice President of China Oncology and Business Unit Head, effective October 29th.

One-Year Preclinical Study of Edasalonexent, a Novel Inhibitor of NF-kB, in Animal Models of Duchenne to Investigate Potential Improved Cardiac Function

AbbVie will participate in the Evercore ISI HealthConX Conference on Tuesday, November 27, 2018.

Revenue and Profitability Growth Continue on Strength of Business Transformation

Expanded offerings help hospitals and health systems extract value from data to improve patient outcomes, lower costs and recapture revenue